5.2
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
View/Download PDF

Translate this page into:

ORIGINAL ARTICLE
12 (
8
); 3289-3301
doi:
10.1016/j.arabjc.2015.08.012

A systematic approach for reversed phase liquid chromatographic method development of fingolimod hydrochloride via design augmentation

Integrated Product Development Organization, Dr. Reddy’s Laboratories, Bachupally, Hyderabad 500072, India
Department of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Kukatpally, Hyderabad 500085, India

⁎Corresponding author at: Integrated Product Development Organization, Dr. Reddy’s Laboratories Ltd, Survey No.: 42, 45 & 46, Bachupally, Qutubullapur, RR District 500072, A.P., India. Tel.: +91 04044342483. sureshk@drreddys.com (Ramdoss Suresh Kumar) rsureshkumar11@yahoo.in (Ramdoss Suresh Kumar)

Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.

Peer review under responsibility of King Saud University.

Abstract

A stability indicating reversed phase liquid chromatographic (RP-LC) method was developed for the analysis of fingolimod hydrochloride (FIM) and its related compounds in drug substance and its dosage form. Separation of seven related compounds and three degradation products was achieved in a C18 stationary phase with 3 mM tetrabutyl ammonium hydrogen sulfate in 0.02% orthophosphoric acid and acetonitrile in gradient elution. Aqueous mobile phase components and column temperature were optimized through Design of experiments (DoE) for a fixed gradient program. Major degradation products were identified by LC-MS and degradation pathway is proposed. The validation results indicated that the method is sensitive in detection, linear, precise and accurate. The developed method was also demonstrated in UHPLC.

Keywords

LC method development
Stability indicating
DoE
HPLC & UHPLC
Fingolimod and related substances
1

1 Introduction

Fingolimod hydrochloride (FIM) is a novel drug approved for the treatment of multiple sclerosis and for the prophylaxis of acute rejection after solid organ transplantation (Brinkmann et al., 2002; Mandala et al., 2002). FIM mechanism of action is unique as it reduces the number of circulating lymphocytes by preventing their egress from lymph nodes (Rosen et al., 2003; Sanna et al., 2006). Analytical methods for FIM and its metabolites in biological samples were found in the literature (Lee et al., 2007; Min et al., 2002; Berdyshev et al., 2009; Salm et al., 2006; Emotte et al., 2012). In all these reported methods, FIM is quantified only in trace level and there is no information on its potential impurities. An assay method for FIM was reported (Chakravarthy and Sankar, 2005), which is not a stability indicating method and also not suitable for related substances estimation. Extensive review of literature shows that no stability indicating analytical method is available for this high potent medicine. In this work, we described the development of a stability indicating HPLC method for the first time, for the quantification of related substances and assay of FIM in drug substance and in dosage form.

Application of Design of experiments (DoE) for HPLC method optimization and robustness study is widely found in the literature (Monks et al., 2012; Aguiar et al., 1997; Suresh et al., 2012; Wang et al., 2006; Hermann et al., 2002; Biswas et al., 2009). By performing a planned sequence of experiments, called a design, the effects of factors and interactions between them on response variations can be established. This approach helps to identify the optimal conditions easily and makes the method robust.

In this work, the method development begun with screening the mobile phase through traditional approach of changing one factor at a time and optimization was done through DoE. Method optimization was done initially with a two level factorial design with center points. The factorial design indicated the presence of significant curvature which means the optimal conditions predicted by the design may not be reliable. Hence the design was augmented with addition of axial points. Thus, the augmented design which is essentially a central composite design enabled us to predict the optimal condition for desired responses.

In most of the literature DoE was applied to optimize the factors in isocratic methods (Suresh et al., 2012; Wang et al., 2006) or taken gradient ramp as one of the factors for method optimization (Hermann et al., 2002; Biswas et al., 2009). In this work, a gradient program was fixed and through DoE, two mobile phase components and column temperature were optimized for that gradient program. It is important to verify that, whether the predefined gradient program is also influencing the responses measured. For this, we have used a retention window (RTW); a plot of retention time versus responses measured and ensured that the gradient program is not a hidden factor. In this study, we have demonstrated to slice the chromatogram and to modify the gradient program in non-critical region; a way to ensure the quick elution of highly non-polar impurities. A short run time for assay analysis (where impurities can be allowed to merge with each other) was also proposed in this study. The method is validated as per ICH guidelines (ICH Q2(R1), 2005). FIM sample was subjected to forced degradation and through LC-MS analysis probable structure for major impurities was proposed and justified.

Though objective of this work was to develop a HPLC method, chromatographic parameters to operate this method in Ultra high pressure Liquid chromatography (UHPLC) are also presented for UHPLC users. A systematically developed robust HPLC method can be easily scaled to UHPLC using standard formula; which was demonstrated in this study.

2

2 Experiments

2.1

2.1 Materials and methods

2.1.1

2.1.1 Chemicals & reagents

FIM and impurities 1–7 (Fig. 1) were synthesized at Dr. Reddy’s (Hyderabad, India) and completely characterized using NMR, Mass and IR spectroscopy. FIM capsules formulated in Dr. Reddy’s laboratories were used for the study. Tetrabutyl ammonium hydrogen sulfate (TBAHS) and ortho phosphoric acid (oPA) (85%) were obtained from MerckKGaA (Darmstadt, Germany). Acetonitrile of gradient grade was obtained from Rankem (New Delhi, India). HPLC grade water was obtained from Milli-Q water purification system (Millipore, Milford, MA, USA).

Structure of fingolimod HCl and related compounds.
Figure 1
Structure of fingolimod HCl and related compounds.

2.1.2

2.1.2 Columns & instruments

The HPLC analytical column used was an X-Bridge C18 (150 mm × 4.6 mm, 3.5 μ) and the UHPLC column used was BEH-C18 (50 mm × 2.1 mm, 1.7 μ). The columns were manufactured by Waters (Waters Corporation, Milford, MA, USA).

LC1: Alliance 2695 separation module equipped with PDA detector (Waters) was used for specificity and development studies. LC2: Agilent 1200 series equipped with VWD (Agilent Technologies, Waldbronn, Germany) was used for validation parameters.

pH meter: Metrohm 780 (Metrohm AG, Herisaw, Switzerland).

2.1.3

2.1.3 Software

LC1 and LC2 were monitored with Empower 2 software (Waters). Design Expert version 8.0.7.1 (Stat-Ease Inc., Minneapolis) was used for experimental designs and interpretation. Microsoft Excel 2007 was used for analysis of validation results.

2.1.4

2.1.4 Chromatographic condition (HPLC)

Mobile phase A, 3 mM TBAHS and 0.02% oPA in water; mobile phase B, acetonitrile: water (9:1, v/v). Flow rate, 1.0 ml/min; column oven temperature, 60 °C; injection volume, 10 μl; and wavelength, 218 nm. Diluent for drug substance preparation is water and acetonitrile (7:3, v/v) and for drug product is 0.1% HCl in methanol: water (1:1, v/v).

Gradient program for related substances: T/%B: 0/30, 30/50, 35/80, 40/80, 45/100, 50/100. Gradient program for assay: T/%B: 0/40, 15/60, 15.1/100, 20/100.

A minimum of 10 min re-equilibration time is required between runs.

Sample concentration for related substances is 1.4 mg/ml and diluted standard of FIM for external quantification of related substances is 0.0014 mg/ml. Sample concentration for assay of FIM is 0.07 mg/ml.

For method validation, the limit for impurities 1–7 was specified as 0.15% and for unknown impurity the limit was kept as 0.10%.

2.1.5

2.1.5 Preparation of sample solution for drug product

The sample solution for related substances analysis was prepared from a 30 capsule composite sample. A 25 capsule equivalent mass of the capsule contents was mixed with 10 ml of diluent. The solution was sonicated for 30 min with intermittent shaking with bath temperature of 20 °C. Further the sample solution was centrifuged at 4000 rpm for 10 min. The supernatant liquid was used for related substances analysis. 1/20th concentration of related substances preparation was used for assay analysis.

2.1.6

2.1.6 LC-MS condition

The mobile phase A was kept as 0.1% trifluoro acetic acid. All other chromatographic conditions are as described in Section 2.1.4. Agilent 1100 series liquid chromatograph (Agilent Technologies, Inc., Santa Clara, CA, USA) coupled with an Applied Biosystems 4000 Q Trap triple quadruple mass spectrometer with Analyst 1.4 software, MDS SCIEX, USA (Thermo Scientific, Sunnyvale, CA, USA) was used for the mass identification of the degradation products. The analysis was performed in positive electro-spray/positive ionization mode with an ion source voltage of 5000 V and a source temperature of 450 °C. GS1 and GS2 were optimized to 30 and 35 psi, respectively. The curtain gas flow was 20 psi.

2.2

2.2 Validation experiments

2.2.1

2.2.1 Precision

The repeatability of the related substance method was checked by injecting six individual preparations of FIM spiked with impurities 1–7 at 100% and 150% of specification level. Percentage RSD for the content of each impurity was calculated. Repeatability of the assay method was checked by injecting six preparations of FIM at three different concentrations (0.035, 0.07 and 0.105 mg/ml) and calculated % RSD for the content of FIM. The intermediate precision of the method was also evaluated using different analyst, on a different day with different make instrument in a laboratory located at different premise of Dr. Reddy’s.

2.2.2

2.2.2 Limit of detection (LOD) and limit of quantification (LOQ)

The LOD and LOQ for impurities and FIM were estimated by signal to noise ratio method (ICH Q2(R1), 2005). Precision study was also carried at the LOQ level by injecting six individual preparations of impurities and FIM and calculating the % RSD of the area. Accuracy at LOQ level was evaluated in triplicate for the impurities by spiking the impurities at the estimated LOQ level.

2.2.3

2.2.3 Linearity

Linearity test solutions for related substance method were prepared by diluting the impurities stock solution and FIM standard solution to the required concentrations. The solutions were prepared at six concentration levels from LOQ to 150% of specification limit for impurities. The calibration curve was drawn by plotting the peak areas of impurities and FIM versus its corresponding concentration. Linearity test solutions for assay were prepared at six concentration levels from 25% to 150% of assay concentration.

2.2.4

2.2.4 Accuracy

Standard addition and recovery experiments were conducted to determine accuracy of the related substance method. The accuracy was calculated by spiking the impurities in placebo based test solution. The study was carried out in triplicate at 50%, 100% and 150% of the specification level of impurities. The accuracy of the assay was evaluated in triplicate at three concentration levels, i.e. 0.035, 0.07 and 0.105 mg/ml in by spiking the drug substance to placebo based test solution. Placebo is a mixture of mannitol and magnesium stearate. The % recovery was calculated against 0.07 mg/ml of FIM reference standard preparation.

3

3 Results

3.1

3.1 Method development

3.1.1

3.1.1 Selection of column & mobile phase pH

Column with C-18 stationary phase, which was reported earlier for FIM (Emotte et al., 2012) was chosen. To keep the molecule in unionized form, it is essential to keep the pH of the mobile phase at 2 units above the pKa for bases and 2 units below the pKa for acids. FIM being a basic substance; to analyze in unionized form it is essential to maintain the pH above 9.8 (pKa of fingolimod is 7.8). At basic pH, limitation of using high column temperature and dissolution of silica are obvious (Kirkland et al., 1995; Classens et al., 1996). Hence, we decided to go with alternate approach of using an acidic mobile phase and keeping the basic compound in completely ionized form. Hydrophobic nature of FIM (log P is 4.178), makes it possible to analyze in ionized form. Furthermore, the pKa of silanols in the chosen column (X-bridge) is greater than 8, which infers that the silanols on the silica are fully protonated below pH 6.0. Hence at acidic pHa positively charged basic compound does not interact strongly with silanols which may result in a good peak shape. Thus, we decided to operate in acidic pH.

3.1.2

3.1.2 Screening of mobile phase components

To screen the mobile phase components, a moderate polar to non-polar linear gradient program was fixed on a trial basis (T: %A/B as 0: 70/30, 60: 30/70). The other conditions employed for screening the mobile phase were: Flow rate – 1.0 ml/min, column temperature – 25 °C, wavelength 218 nm and injection volume – 10 μl. Impurity spiked solution was injected in each trial.

Most commonly used simple mobile phases were chosen for initial screening. To operate in acidic condition widely used phosphate buffer was chosen. Triethylamine is a well-known mobile phase additive to reduce the peak tailing of basic molecules (Bian et al., 2012; Ruiz et al., 2006; Reta and Carr, 1999). In addition to that we have decided to investigate tetrabutyl ammonium hydrogen sulfate (TBAHS) also. TBAHS helps in reducing the tailing of basic compound through various mechanisms and mainly by masking the residual silanol activity of a C18 stationary phase (Wells and George, 1982). A combination of TBAHS and oPA was reported for a chromatographic separation of basic drug (Fletouris et al., 1996).

To select aqueous phase components and organic modifier, we decided to use the traditional approach of Changing One Single (or separate) factor at a Time (COST), while keeping other factors constant. This approach, is also called as One Factor at a Time (OFAT) is convenient for a limited number of predetermined experiments. The outcome of COST is given in Table 1.

Table 1 Mobile phase screening trials – Changing One Single factor at a Time (COST).
Trial Mobile phase A Mobile phase B RT of FIM Tailing factor Imp-3 & 4 resolution
1 10 mM KH2PO4 – pH 3.0 Acetonitrile: water (90:10) 30.2 4 0
2 10 mM TBAHS + 10 mM oPA (pH 2.2) Acetonitrile: water (90:10) 23.1 0.85 0.5
3 10 mM KH2PO4 + 10 mM TEA pH 3.0 Acetonitrile: water (90:10) 22.5 2.9 0
4 10 mM TBAHS + 10 mM oPA (pH 2.2) Methanol: water (90:10) 36.5 3.1 0

Table 1 shows clearly that, symmetric peak can be achieved with TBAHS mobile phase (Trial 2). Almost similar result was obtained with phosphate buffer and Triethylamine mobile phase. In the trials 1 and 3, separation between imp-3 and 4 was not achieved. Hence trial-2 was repeated with methanol as organic phase (trial-4). In trial-4, FIM was observed as asymmetric peak and impurities 3–5 were merged together. Hence, we decided to work further with TBAHS and oPA as aqueous mobile phase components and acetonitrile as organic modifier.

3.1.3

3.1.3 Selection of factors & responses for method optimization

The optimization of the method has been carried out through DoE. Factors and the levels to be optimized through DoE are given in Table 2. Rationale for choosing the factors and their range is discussed below.

Table 2 Factors and levels to be studied by DoE.
Factor Unit Low (−1) High (+1)
TBAHS mM 1 10
oPA % 0 0.1
Column temperature °C 30 65

In trial-2 (Table 1), tailing factor of FIM is below 1.0. The slight fronting of peak may be an indication of TBAHS more than the required amount. Hence we decided to study TBAHS from high (10 mM) to low (1 mM) concentration. TBAHS is generally used in combination with other phosphate or acetate buffer (Bielejewska and Gold, 2005). pH of an aqueous solution of TBAHS (10 mM) with or without oPA (0.1%) is about 2.2. Without combining the phosphate or acetate buffer, TBAHS alone was used as mobile phase additive for chromatographic elution of basic compound (Plum et al., 2003). Hence, we decided to investigate that whether oPA is really required to include in mobile phase and it was studied from zero level.

Beneficial effect of higher column temperature on resolution of closely eluting peaks has been demonstrated adequately (Gant et al., 1979; Lestremau et al., 2006). To improve the resolution of closely eluting pair Imp-3 and 4, we have decided to study the higher column temperature. Based on column capacity to withstand higher temperature at acidic pH and LC instrument capability, it was decided to study to the maximum of 65 °C.

From COST trials it was understood that resolution between imp-3 and 4 and tailing factor of FIM were critical tasks to achieve. In addition to that, monitoring the resolution between FIM and imp-3 is considered important, as they are closely eluting peaks. Hence, these three responses were chosen for method optimization.

3.1.4

3.1.4 Execution of DoE

Gradient program, flow rate, injection volume and wavelength used for COST trials (Section 3.1.2) were adopted for DoE runs. A full factorial design with center points in 4 replicates was executed for three factors (Table 3).

Table 3 3A. Full factorial design with center points and responses studied.
Standard run Run order Point type Factor A Factor B Factor C Responses Retention time
(for method optimization) (for RT-window plot)
Imp-3 & 4 resolution (R1) Tailing factor (R2) FIM & Imp-3 resolution (R3) FIM Imp-3 Imp-4
6 1 Factorial 10 0 65 0 0.82 1.82 19.7 20.5 20.7
11 2 Center 5.5 0.05 47.5 1.11 1.62 3.96 21.2 22.6 23.0
7 3 Factorial 1 0.1 65 1.38 3.69 2.78 20.2 22.7 23.3
12 4 Center 5.5 0.05 47.5 1.11 1.61 3.94 21.2 22.6 23.0
1 5 Factorial 1 0 30 1.02 3.21 3.9 24.2 26.7 27.0
4 6 Factorial 10 0.1 30 0.54 0.81 2.78 23.6 24.7 24.9
9 7 Center 5.5 0.05 47.5 1.11 1.57 3.91 21.2 22.6 23.0
2 8 Factorial 10 0 30 0 0.74 1.64 24.4 25.4 25.4
3 9 Factorial 1 0.1 30 1.04 3.88 3.6 24.8 27.7 28.0
5 10 Factorial 1 0 65 1.42 2.94 3.08 19.4 21.5 22.0
10 11 Center 5.5 0.05 47.5 1.11 1.61 3.92 21.2 22.6 23.0
8 12 Factorial 10 0.1 65 0.92 1.12 2.96 18.6 19.6 19.9
3B. Augmented design (CCD) with axial points
15 13 Axial 5.5 0 47.5 0.75 0.98 3.58 22.5 23.7 24.1
17 14 Axial 5.5 0.05 30 0.8 1.36 4.47 23.2 24.7 25.0
18 15 Axial 5.5 0.05 65 1.21 1.72 3.36 18.3 19.7 20.1
14 16 Axial 10 0.05 47.5 0.8 0.85 2.84 21.9 22.9 23.2
19 17 Center 5.5 0.05 47.5 1.12 1.62 3.93 21.2 22.6 23.0
20 18 Center 5.5 0.05 47.5 1.12 1.61 3.93 21.2 22.6 23.0
13 19 Axial 1 0.05 47.5 1.34 3.75 3.16 22.4 25.1 25.6
16 20 Axial 5.5 0.1 47.5 1.15 1.8 3.85 21.5 23.0 23.4

Standard run, run order adopted and the measured outcome (responses) is given in Table 3A. Statistically significant curvature (P < 0.05) (Table 4) was observed for all three responses, which suggest that a quadratic model may be a better fit. Hence the design was augmented by including six axial points. Axial points together with the factorial and center points constitute a central composite design (CCD). Outcome of the augmented runs is given in Table 3B.

Table 4 Regression model & statistical tools.
Responses Regression model Model P-value Adj R2 %CV AP
Augmented design – central composite design
Imp-3 & 4 resolution 1.11–0.39A + 0.18B + 0.15C + 0.19AB − 0.18B2 − 0.13C2 <0.0001 0.94 9.8 27.6
Tailing factor 1.59–1.31A + 0.26B + 0.03C − 0.13AB + 0.11AC + 0.73A2 − 0.18B2 <0.0001 0.99 6.9 39.0
FIM & Imp-3 resolution 3.88–0.45A + 0.20B − 0.24C + 0.36AB + 0.25AC − 1.02A2 <0.0001 0.91 6.6 16.4
Factorial design Model P-value Curvature P-value
Imp-3 & 4 resolution 0.90–0.43A + 0.18B + 0.14C + 0.19AB <0.0001 0.0014
Tailing factor 1.97–1.28A + 0.22B − 0.01C − 0.13AB + 0.11AC <0.0001 0.0086
FIM & Imp-3 resolution 3.19–0.52A + 0.21B − 0.16C + 0.36AB + 0.25AC <0.0001 <0.0001

Adj – adjusted, CV – coefficient of variation, AP – adequate precision.

3.1.5

3.1.5 Data interpretation

Classical statistical tools (Suresh et al., 2012) were employed to validate each model and reported in Table 4. In the present study, the adjusted R2 was >0.90 which revealed that the experimental data show a good fit with the polynomial equations. The adequate precision value greater than 4 is desirable. In this study, the value was found to be in the range of 16.4–39 and hence the model is significant for the optimization process. A model can be considered reasonably reproducible if the coefficient of variation (C.V.) is less than 10% and in this study all the models meet the requirement.

For an experimental design with three factors, the model including linear, quadratic, and cross terms can be expressed as

(1)
Y = β 0 + β a A + β b B + β c C + β ab AB + β ac AC + β bc BC + β aa A 2 + β bb B 2 + β cc C 2 where Y is the response to be modeled, β is the regression coefficient and A, B and C represent factors. Insignificant terms (P > 0.05) are eliminated and the reduced models for factorial design and CCD are given in Table 4.

The magnitudes of the coefficients in the regression equation (Table 4) were used as the basis for judging statistical significance and illustrating the relative effects of linear, quadratic and cross product interactions between the parameters. By using regression equations and the response surface graphs (Fig. 2), conclusions were drawn as follows: (1) Resolution between imp-3 and 4 (R1), which was the critical task to achieve, increases with increase in column temperature. TBAHS concentration should be kept low to improve the R1. Phosphoric acid has positive effect on R1. Hence it should be included in the mobile phase. (2) USP tailing factor (R2) decreases with increase in TBAHS concentration and column temperature has no effect on peak tailing. Inclusion of oPA will increase the R2. Hence concentration of oPA should be limited in the mobile phase. (3) Low TBAHS is preferred for improved resolution between FIM and Imp-3. Increase in column temperature may decrease the resolution.

Response surface graphs. Each response is plotted at two temperature, (i) 30 °C and (ii) 60 °C (method condition). Red surface on the graph indicates the maximum response. Response decreases toward blue region.
Figure 2
Response surface graphs. Each response is plotted at two temperature, (i) 30 °C and (ii) 60 °C (method condition). Red surface on the graph indicates the maximum response. Response decreases toward blue region.

3.1.6

3.1.6 Fixing the responses for method optimization

Minimum tailing and maximum resolution are desired for a chromatographic method. To optimize the method lower and upper values of the responses are defined and given in Table 5. Rationale for fixing the responses is discussed below:

Table 5 Method optimization goals.
Response Desirability Design space
Goal Lower Upper
Imp-3 & 4 resolution (R1) Maximize 1 1.2 Not less than 1.0
Tailing factor (R2) Minimize 2.5 3 Not more than 2.5
FIM and Imp3 resolution (R3) Maximize 3 3.5 Not less than 3.0

In our experience, a method with resolution between two low level impurities as 1.0 (United States Pharmacopeia, 2011) is good enough for accurate quantification. Hence lower limit kept for resolution between imp-3 and 4 was 1.0.

From Section 3.1.5 it was understood that TBAHS concentration should be kept low to increase the resolution responses (R1 & R3). At low TBAHS concentration tailing factor of FIM would be high. Achieving resolution between the imp-3 and 4 is more important than a perfect symmetrical peak and if tailing factor is high, external quantification method can be adopted for accurate quantification. Hence, an arguably accepted limit for tailing factor was kept.

While proceeding with high tailing factor, quantification of a small impurity (imp-3) which elutes immediately after a big asymmetric peak (FIM) will be accurate, only if it separates very well. Hence the desired resolution is at least 3.0.

Derringer’s desirability function (Parajo et al., 1992) was used to optimize the method for three responses with three different targets. Weights equal to 1 was given for all three responses. Highly desirable regions (Desirability = 1.0) were examined to select the point for normal operation. Contour plot of desirability and design space is given in Fig. 3. From the design space, components of the mobile phase were chosen as 3 mM TBAHS in 0.02% oPA and the column temperature as 60 °C.

A – Design space (overlay plot of effects): yellow region indicates design space. In gray region, responses are below the desired level. Within design space, desirability plot helps to choose the region at which desired responses are at maximum level. The responses and factors at method condition are shown in the flag. Orthophosphoric acid (F(B)) is kept as 0.02%. B – Desirability plot. Red region is highly desirable. Desirability decreases toward blue region. Desirability plot can be used as a tool to choose the region at which desired responses are at maximum level in the design space. Refer Table 5 for criteria and target set for design space and desirability plot.
Figure 3
A – Design space (overlay plot of effects): yellow region indicates design space. In gray region, responses are below the desired level. Within design space, desirability plot helps to choose the region at which desired responses are at maximum level. The responses and factors at method condition are shown in the flag. Orthophosphoric acid (F(B)) is kept as 0.02%. B – Desirability plot. Red region is highly desirable. Desirability decreases toward blue region. Desirability plot can be used as a tool to choose the region at which desired responses are at maximum level in the design space. Refer Table 5 for criteria and target set for design space and desirability plot.

3.1.7

3.1.7 Retention window

To verify that whether the predefined gradient program is a hidden factor in influencing the response, the responses measured are viewed through a RT window (RTW) (Fig. 4); a plot of retention time versus responses studied. Observation of increasing or decreasing trend of responses with respect to RT will be a clear indication of influence of gradient program.

Retention window; a plot of responses versus retention time. No correlation between retention time and response is observed in this scatter plot.
Figure 4
Retention window; a plot of responses versus retention time. No correlation between retention time and response is observed in this scatter plot.

From Fig. 4 it was understood that the responses are not arranged in a linear fashion and no correlation exists between RT and responses. High and low responses are observed within one minute window. For example, in the window of 24–25 min the tailing factor ranges from 0.74 to 3.88 (RTW2). In the window of 25 to 26 min resolution between imp-3 and imp-4 is in the range of 0–1.34 (RTW1) and resolution between FIM and imp-3 ranges from 1.64 to 3.16 (RTW3). Each run experiences same ratio of aqueous and organic mobile phases at a particular RT and hence the variation observed in the responses is concluded as predominant effect of factors studied.

3.1.8

3.1.8 Modification of gradient program

With optimized mobile phase and column temperature, a solution of FIM spiked with impurities was injected in the predefined gradient program (T: %A/B – 0: 70/30, 60: 30/70).

From Fig. 5 it was evident that all the impurities except impurity 7 were eluted before 30 min (slice A) and impurity 7 was eluted at the edge of the gradient program (slice B). Further it was understood that this gradient program is not sufficient enough to elute highly non-polar impurities, which may found in crude or degraded samples.

Chromatogram obtained with DoE optimized mobile phase and column temperature (Section 2.1.4) in the predefined gradient program (T/A:B: 0/70:30, 60/30:70). The chromatogram is sliced into two. Slice A represents the critical phase (T/A:B: 0/70:30, 30/50:50); where the gradient program is not to be changed. Modification of gradient program shall be done in slice B. Mobile phase A:B ratio with respect to time is given in the x-axis.
Figure 5
Chromatogram obtained with DoE optimized mobile phase and column temperature (Section 2.1.4) in the predefined gradient program (T/A:B: 0/70:30, 60/30:70). The chromatogram is sliced into two. Slice A represents the critical phase (T/A:B: 0/70:30, 30/50:50); where the gradient program is not to be changed. Modification of gradient program shall be done in slice B. Mobile phase A:B ratio with respect to time is given in the x-axis.

As the method was optimized for critical separation, it is important to modify the gradient without disturbing DoE outcome. Hence it was decided to maintain the same ramp of the gradient for 30 min and modifying the program after 30 min.

(2)
% B at 30 minutes = I + ( R × 30 ) where I = initial mobile phase B% = 30% and R = ramp.
(3)
R = ( % B at Final - % B at initial ) / Time of the gradient run

Here, the calculated R is 0.66 and %B at 30 min is 50. The calculated ramp is represented in Fig. 5 at every 15 min intervals. The gradient program was modified for the run after 30 min, with few trials. A chromatogram obtained with the modified gradient program (finalized method conditions, refer Section 2.1.4) is given in Fig. 6. Finalized method ensured the elution of imp-7 quickly and secured the place for elution of highly non-polar impurities.

Chromatogram obtained with finalized method conditions (refer Section 2.1.3) for related substances. Critical separation is shown in zoom.
Figure 6
Chromatogram obtained with finalized method conditions (refer Section 2.1.3) for related substances. Critical separation is shown in zoom.

A rapid gradient program was proposed for assay method and ensured that no peak is left merged with FIM. Sample concentration for assay analysis is twenty times less than related substances analysis and hence the observed tailing factor is around 1.1. Assay method chromatogram of sample spiked with impurities is given in Fig. 7.

Chromatogram obtained with finalized method conditions (refer Section 2.1.4) for assay.
Figure 7
Chromatogram obtained with finalized method conditions (refer Section 2.1.4) for assay.

3.1.9

3.1.9 Specificity & mass balance study

Forced degradation was conducted on FIM sample to ensure the specificity of the method. Each degraded sample was injected in both related substances program and assay program. Condition adopted for degradation and the mass balance is tabulated in Table 6.

Table 6 Mass balance study.
Degradation conditions Total impurities (% w/w) Assay (% w/w) Mass balance (%w/w)
As such sample 0.10 99.5 99.6
Water hydrolysis (Reflux, 48 h) 0.11 99.7 99.8
Thermal degradation (90 °C, 10 days) 0.10 99.5 99.6
Photo degradation (as per ICH) 0.10 99.8 99.9
Acid degradation (2 M HCl, 70 °C, 48 h) 0.34 99.4 99.7
Base degradation (0.5 M NaOH, RT, 48 h) 11.60 87.0 98.6
Peroxide degradation (3% H2O2, 48 h) 4.40 94.5 98.9

From Table 6 it is evident that FIM is very stable with respect to temperature, light (ICH Q1B, 1996) and water hydrolysis and almost stable to acid hydrolysis. The molecule is sensitive to base hydrolysis and oxidation. Proposed degradation pathway is given in Fig. 8.

Proposed degradation pathway for oxidation and base degradation.
Figure 8
Proposed degradation pathway for oxidation and base degradation.

A mixture of methanol: water (8:2, v/v) was used for base degradation, as the molecule was getting precipitated when using diluent as per method condition (water:acetonitrile, 30:70). The major impurity observed at the RRT 1.25 in the base degraded sample was subjected to LCMS analysis. m/z of the impurity was found to be 350.4. Reaction of aralkyl amine with carbon dioxide (CO2) is well known (Wright and Moore, 1948). On treating with sodium hydroxide (NaOH), the HCl (counter ion of fingolimod base) was getting neutralized and the free amine was readily available for reaction with CO2 and forms carbamate anion (Jackson et al., 2011). Formation of carbamate anion is possible even with atmospheric CO2 (Wright and Moore, 1948) and it was observed in this study. Based on this, structure hitherto possible and Mass spectra are given in Fig. 9. Two major impurities formed in peroxide degraded sample were identified by LCMS analysis. m/z [M + H]+ of the impurities were 340.2 and 322.0. Formation of unstable hydro peroxide and ketones is possible during oxidation of alkyl aromatics (Rao and Awasthi, 2007) and in general benzylic protons are highly reactive (Morrison and Boyd, 1992). Based on these two facts structure hitherto possible are proposed in Fig. 9 along with their mass spectra.

Mass spectra and chromatograms of base & oxidation degradation. A – Mass spectra and a possible structure of the impurity (carbamate anion of FIM). B – Chromatogram of base degradation. C – Mass spectra of oxidation degradation product-1. D – Mass spectra of oxidation degradation product-2. E – Chromatogram of oxidation degradation. (For LC-MS condition refer Section 2.1.6).
Figure 9
Mass spectra and chromatograms of base & oxidation degradation. A – Mass spectra and a possible structure of the impurity (carbamate anion of FIM). B – Chromatogram of base degradation. C – Mass spectra of oxidation degradation product-1. D – Mass spectra of oxidation degradation product-2. E – Chromatogram of oxidation degradation. (For LC-MS condition refer Section 2.1.6).

The FIM samples analyzed did not have the base degraded impurity and oxidized impurities. Further, under accelerated stability conditions (40 ± 2 °C, 75 ± 5% RH for 6 months) the molecule is very stable and no degradation impurity is observed. Hence further attempts were not given for isolation or characterization of these degradants. Mass balance close to 99% (Table 6) shows the stability indicating power of the method. Homogeneity of the FIM peak was ensured with Photo Diode Array detector.

3.1.10

3.1.10 Chromatographic conditions for UHPLC

Mobile phase (3 mM TBAHS in 0.02% oPA) and column temperature (60 °C) as optimized through DoE were used for UHPLC method. The HPLC parameters used for DoE study: Gradient program (T/%A:%B: 0/70:30, 60/30:70), flow rate (1.0 ml/min) and injection volume (10 μl) were scaled to operate the method in UHPLC system. The elution was carried out in a BEH-C18 column (Waters). The dimension of the UHPLC column and formula used for scaling the method to UHPLC is given in Table 7.

Table 7 Optimization of the method for UHPLC.
HPLC1 UHPLC2
Parameters
Column length (mm) (L) 150 50
Column internal diameter (mm) (dc) 4.6 2.1
Column particle size (μm) (dp) 3.5 1.7
Column volume (Cv) 2.49 0.17
Void volume (V0) 1.69 0.12
Chromatographic conditions
Injection volume (μl) (Vi) 10 0.69
Flow rate (ml/min) (F) 1 0.43
Gradient time (min) (tg) for 60 9.9
%B 30–70
Formulae used for conversion to UHPLC
Cv = L × Π × (dc/2)2 × 1/1000 V0 = Cv × 68/100
Vi2 = Vi1 × (dc22 × L2/dc12 × L1) F2 = F1 × (dc22/dc12) × (dp1/dp2)
tg2 = tg1 × (V02/V01) × (F1/F2)

A chromatogram obtained with UHPLC method is given in Fig. 10, which is much resembled to HPLC chromatogram of Fig. 5. Interested UHPLC users can further modify the gradient program as described in Section 3.1.8.

Chromatogram obtained with UHPLC. Flow rate: 0.44 ml/min, Injection volume: 0.7 μl, Gradient program: T/A/B: 0/70/30, 10/30/70. For mobile phase and other chromatographic conditions refer Section 2.1.4.
Figure 10
Chromatogram obtained with UHPLC. Flow rate: 0.44 ml/min, Injection volume: 0.7 μl, Gradient program: T/A/B: 0/70/30, 10/30/70. For mobile phase and other chromatographic conditions refer Section 2.1.4.

3.2

3.2 Validation

3.2.1

3.2.1 Precision

The % RSD for the content of impurities is within 2% for each specified impurity during repeatability and intermediate precision studies. % RSD for assay content during repeatability and intermediate precision studies is <0.4% for drug substance and <1.0% for drug product. The result indicates that method is precise.

3.2.2

3.2.2 Limit of detection & limit of quantification

LOD for Imp-1, 2, 3, 4, 5, 6, 7 and FIM is 0.005%, 0.004%, 0.005%, 0.005%, 0.005%, 0.005%, 0.005%, 0.003% and 0.004% respectively. LOQ for Imp-1, 2, 3, 4, 5, 6, 7 and FIM is 0.020%, 0.016%, 0.021%, 0.020%, 0.020%, 0.021%, 0.012% and 0.016% respectively. The LOD, LOQ values are with respect to sample concentration of 1.4 mg/ml and injection volume of 10 μl% RSD for the area at LOQ level is below 10% for all impurities. Recovery for impurities ranges from 89% to 96%.

3.2.3

3.2.3 Linearity

The correlation coefficient and coefficient of determination (r2) for impurities and FIM is ⩾0.999. In related substances method, % Y-intercept value for each impurity or FIM is within ±3% of response at 100% concentration level. For assay, the correlation coefficient and r2 of FIM is 0.999 and % Y-intercept value is 0.3% of response at 100% concentration level. To assess the appropriateness of using a linear regression model to fit the data, residual plots were produced. The points in these plots were randomly distributed around the horizontal zero axis suggesting that the linear model gives a good fit of the data.

3.2.4

3.2.4 Accuracy

Individual and average recovery in three preparations and at three concentrations for impurities is within 100 ± 10%. For assay of FIM the recovery is within 100 ± 0.5% for drug substance and within 100 ± 2% for drug product.

3.2.5

3.2.5 Robustness

Design space (Fig. 3) of the method indicates robustness in terms of column temperature, and concentration of mobile additives (TBAHS and oPA). Mobile phase flow rate, which is another parameter normally performed during robustness checking (ICH Q2(R1), 2005) was also studied at ±0.2 ml/min and ensured that the system meets the suitability criteria (Table 5).

4

4 Conclusion

A stability indicating method was developed for FIM drug substances by using DoE. The CCD was reached via augmenting a full factorial design with the intention of reducing the number of runs, if possible. We have demonstrated to use RT window as a verification tool, while executing a DoE in a fixed gradient program. RT window used in this study was a logical interpretation based on general behavior of compounds in a reversed phase chromatography. The method is specific for the quantification of FIM and its related compounds including degradation products. The developed method is robust, reliable and highly sensitive in detection, user friendly and can be used for quality control and stability studies of FIM. Assay of FIM can be executed in the same chromatographic system of related substances with a short run time method. In this study, scaling a systematically developed robust HPLC method to UHPLC appears as simple task.

Acknowledgment

Authors wish to thank management of Dr. Reddy’s for supporting this research work.

References

  1. , , , , , . Optimisation of the reversed phase liquid chromatographic separation of atovaquone, proguanil and related substances. J. Pharm. Biomed. Anal.. 1997;15:781-1787.
    [Google Scholar]
  2. , , , , , , , , , . FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells. J. Biol. Chem.. 2009;284:5467-5477.
    [Google Scholar]
  3. , , , . Effects and mechanism characterization of ionic liquids as mobile phase additives for the separation of matrine-type alkaloids by liquid chromatography. J. Pharm. Biomed. Anal.. 2012;58:163-167.
    [Google Scholar]
  4. , , . RP-HPLC separation of acetic and trifluoroacetic acids using mobile phase with ion interaction reagent and without buffer. Chem. Anal. (Warsaw). 2005;50:387-395.
    [Google Scholar]
  5. , , , , , , . A simple and efficient approach to reversed-phase HPLC method screening. J. Pharm. Biomed. Anal.. 2009;49:692-701.
    [Google Scholar]
  6. , , , , , , , , , , , , , . The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem.. 2002;277:21453-21457.
    [Google Scholar]
  7. , , . LC determination of fingolimod in bulk and its pharmaceutical formulation. Imper. J. Med. Org. Chem.. 2011;1:10-17.
    [Google Scholar]
  8. , , , . Effect of buffers on silica-based column stability in reversed-phase HPLC. J. Chromatogr. A. 1996;728:259-270.
    [Google Scholar]
  9. , , , , , . Fast simultaneous quantitative analysis of FTY720 and its metabolite FTY720-P inhuman blood by on-line solid phase extraction coupled with liquid chromatography–tandem mass spectrometry. J. Pharm. Biomed. Anal.. 2012;58:102-112.
    [Google Scholar]
  10. , , , , . Trace analysis of albendazole and its sulphoxide and sulphone metabolites in milk by liquid chromatography. J. Chromatogr. B. 1996;687:427-435.
    [Google Scholar]
  11. , , , . Systematic approach to optimizing resolution in reversed- phase liquid chromatography, with emphasis on the role of temperature. J. Chromatogr. A. 1979;185:153-177.
    [Google Scholar]
  12. , , , . Evaluation of essential parameters in the chromatographic determination of cyclosporin A and metabolites using a D-optimal design. J. Pharm. Biomed. Anal.. 2002;30:1263-1276.
    [Google Scholar]
  13. ICH Harmonized Tripartite Guideline Q1B, 1996. Stability Testing: Photo Stability Testing of New Drug Substances and Products.
  14. ICH Harmonised Tripartite Guideline Q2 (R1), 2005. Validation of Analytical Procedures: Text and Methodology.
  15. , , , . Tandem mass spectrometry measurement of the collision products of carbamate anions derived from CO2 capture sorbents: paving the way for accurate quantitation. J. Am. Soc. Mass Spect.. 2011;22:1420-1431.
    [Google Scholar]
  16. , , , . High pH mobile phase effects on silica-based reversed-phase high-performance liquid chromatographic columns. J. Chromatogr. A. 1995;691:3-19.
    [Google Scholar]
  17. , , , , , . A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography. Prostaglandins Other Lipid Mediators. 2007;84:154-162.
    [Google Scholar]
  18. , , , , , . High-efficiency liquid chromatography on conventional columns and instrumentation by using temperature as a variable. I. Experiments with 25 cm × 4.6 mm I.D., 5 μm ODS columns. J. Chromatogr. A. 2006;1109:191-196.
    [Google Scholar]
  19. , , , , , , , , , , , , , , , , . Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 2002;296:346-349.
    [Google Scholar]
  20. , , , , , . Simultaneous quantitative analysisof sphingoid base 1-phosphates in biological samples by o-phthalaldehydeprecolumn derivatization after dephosphorylation with alkaline phosphatase. Anal. Biochem.. 2002;303:167-175.
    [Google Scholar]
  21. , , , , , . Multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation. J. Chromatogr. A. 2012;1232:218-230.
    [Google Scholar]
  22. , , . Organic Chemistry (Sixth ed.). Prentice-Hall of India; . p. :564-568.
  23. , , , , . Empirical modeling of eucalyptus wood processing. Bioprocess Eng.. 1992;8:129-136.
    [Google Scholar]
  24. , , , . Process monitoring of anaerobic azo dye degradation by high-performance liquid chromatography–diode array detection continuously coupled to membrane filtration sampling modules. J. Chromatogr. A. 2003;987:395-402.
    [Google Scholar]
  25. , , . Review: oxidation of alkylaromatics. E-J. Chem.. 2007;4:1-13.
    [Google Scholar]
  26. , , . Comparative study of divalent metals and amines as silanol-blocking agents in reversed-phase liquid chromatography. J. Chromatogr. A. 1999;855:121-127.
    [Google Scholar]
  27. , , , . Egress: a receptor-regulated step in lymphocyte trafficking. Immunol. Rev.. 2003;195:160-177.
    [Google Scholar]
  28. , , , . Ionic liquids versus triethylamine as mobile phase additives in the analysis of β-blockers. J. Chromatogr. A. 2006;1119:202-208.
    [Google Scholar]
  29. , , , , . Measurement and stability of FTY720 in human whole blood by high-performance liquid chromatography–atmospheric pressure chemical ionization-tandem mass spectrometry. J. Chromatogr. B. 2006;843:157-163.
    [Google Scholar]
  30. , , , , , , , , , , , , , . Enhancement of capillary leakage and restoration of lymphocyte egress by achiral S1P1 antagonist in vivo. Nat. Chem. Biol.. 2006;2:434-441.
    [Google Scholar]
  31. , , , , , , . Development of a RP-LC method for a diastereomeric drug valganciclovir hydrochloride by enhanced approach. J. Pharm. Biomed. Anal.. 2012;70:101-110.
    [Google Scholar]
  32. United States Pharmacopeia, 2011.Capecitabine Monograph, 34th ed., United States Pharmacopeial Convention, Rockville, MD, USA, pp. 2146–2148.
  33. , , , . Optimising reversed-phase liquid chromatographic separation of an acidic mixture on a monolithic stationary phase with the aid of response surface methodology and experimental design. J. Chromatogr. A. 2006;1105:199-207.
    [Google Scholar]
  34. , , . The effect of silanol masking on the recovery of picloram and other solutes from a hydrocarbonaceous pre-analysisextraction column. J. Liquid Chromatogr.. 1982;5:2293-2309.
    [Google Scholar]
  35. , , . Reactions of aralkyl amines with carbon dioxide. J. Am. Chem. Soc.. 1948;70:3865-3866.
    [Google Scholar]
Show Sections